Asante is excited to announce the global expansion of our secondaries business

Asante is excited to announce that Director Sam Cantor is relocating to our New York City office, further strengthening the global expansion of our secondaries business.

In collaboration with our London office, Sam and his team will ensure Asante is fully equipped to meet – and exceed – the evolving needs of our GP clients. Leveraging their deep LP relationships and demonstrated industry expertise, our global team will work in unison to further advance our secondary capabilities and streamline Asante’s offerings.

We look forward to delivering tailored, thoughtful solutions for clients and partners that will position them for long-term success.

Asante Capital congratulates partner Abingworth on the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million

We are delighted to share that Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million.

Asante Capital congratulates its partner Norvestor on closing Norvestor IX SCSp (“Norvestor IX”) at its hard cap of €1.5 billion

We are delighted to share that Norvestor, a leading private equity firm in the Nordics, has closed Norvestor IX SCSp (“Norvestor IX”) at its hard cap of €1.5 billion, exceeding its €1.25 billion target, despite a challenging fundraising environment.

Asante Capital Named to PEI’s Inaugural Top Private Equity Placement Agents of 2023

Asante Capital was ranked as one of Private Equity International’s Top Private Equity Placement Agents of 2023, ranking fourth for overall capital raised across all private market strategies and third for both the APAC and North America regions. PEI’s inaugural list looked at the most active placement agents and winners were chosen based on their performance, rather than submission.